Endovascular device engagement

• US 10,076,399 B2
• Filed: 09/13/2013
• Issued: 09/18/2018
• Est. Priority Date: 09/13/2013
• Status: Active Grant

• Current Assignee: Covidien LP (Medtronic Plc)
• Original Assignee: Covidien LP (Medtronic Plc)
• Inventors: Davidson, James A.
• Primary Examiner(s): Holwerda, Kathleen
• Assistant Examiner(s): Lauer, Christina
• Application Number:
  US14/026,302
• Publication Number:
  US 20150080937A1
• Time in Patent Office: 1,831 Days
• Field of Search: 606200
• CPC Class Codes: A61B 17/22 Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for dilators A61M29/00
• CPC Class Codes: A61B 17/221 Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions surgical snare instruments A61B17/32056
• CPC Class Codes: A61B 2017/00867 shape memory effect
• CPC Class Codes: A61B 2017/00893 pharmaceutically effective
• CPC Class Codes: A61B 2017/22034 for gripping the obstruction or the tissue part from inside
• CPC Class Codes: A61B 2017/2215 having an open distal end
• CPC Class Codes: A61B 2090/3966 Radiopaque markers visible in an X-ray image
• CPC Class Codes: A61F 2/01 Filters implantable into blood vessels
• CPC Class Codes: A61F 2/011 Instruments for their placement or removal
• CPC Class Codes: A61F 2002/016 made from wire-like elements

Abstract

A medical device, configured to perform an endovascular therapy, e.g., thrombectomy, can comprise an elongate manipulation member and an intervention member. The intervention member can comprise a proximal end portion and a mesh. The proximal end portion can be coupled with the distal end portion of the elongate manipulation member. The mesh can have a plurality of cells and, be compressible to a collapsed configuration for delivery to an endovascular treatment site through a catheter, and be self-expandable from the collapsed configuration to an expanded configuration. At least a portion of the mesh, from a first location to a second location along the mesh, can be configured such that an amount of cell deformation in response to longitudinally directed tensile forces decreases by less than 5% or increases in a distal direction along the portion of the mesh.

Claims

1. A medical device configured to perform an endovascular therapy, the device comprising:

an elongate manipulation member comprising a distal end portion; and

an intervention member comprising a proximal end portion and a mesh, the proximal end portion being coupled with the distal end portion of the elongate manipulation member, the mesh having a proximal mesh end, a distal mesh end, and a mesh length from the proximal end to the distal end, the mesh having a plurality of cells and being compressible to a collapsed configuration for delivery to an endovascular treatment site through a catheter and being self-expandable from the collapsed configuration to an expanded configuration, and wherein at least a portion of the mesh, from a first location to a second location along the mesh, is configured such that an amount of cell deformation in response to longitudinally directed tensile forces decreases by less than 5% or increases in a distal direction along the portion of the mesh, the first and second locations being longitudinally separated by a distance that is more than half of the mesh length;

wherein the mesh is generally cylindrical in the absence of external forces;

wherein, in a longitudinal row of at least three cells, each cell includes first and second struts (i) bounding a proximal portion of the cell and (ii) diverging in a distal direction;

wherein, in the longitudinal row, each cell distally adjacent to another cell has a larger proximal inscribed strut angle between the first and second struts than has the another cell; and

wherein the first struts of all cells in the longitudinal row of at least three cells have substantially equal lengths.

2. The medical device of claim 1, wherein the portion of the mesh, from the first location to the second location along the mesh, is configured such that the amount of cell deformation in response to longitudinally directed tensile forces does not decrease in a distal direction along the portion of the mesh.

3. The medical device of claim 1, wherein the portion of the mesh, from the first location to the second location along the mesh, is configured such that the amount of cell deformation in response to longitudinally directed tensile forces increases in a distal direction along the portion of the mesh.

4. The medical device of claim 1, wherein the first and second locations are longitudinally separated by a distance that is at least two thirds of the mesh length.

5. The medical device of claim 1, wherein the first and second locations are longitudinally separated by a distance that is at least three quarters of the mesh length.

6. The medical device of claim 1, wherein the first and second locations are longitudinally separated by a distance that is at least 90% of the mesh length.

7. The medical device of claim 1, wherein, in the longitudinal row, each cell distally adjacent to another cell has a larger interior bounded area than has the another cell, and

wherein each cell distally adjacent to another cell in the longitudinal row has a larger maximum cell width than has the another cell.

8. A medical device configured to perform an endovascular therapy, the device comprising:

an elongate manipulation member comprising a distal end portion; and

an intervention member comprising a proximal end portion and a plurality of cells forming a mesh, the proximal end portion being coupled with the distal end portion of the elongate manipulation member, the mesh having a proximal mesh end, a distal mesh end, and a mesh length from the proximal end to the distal end, the mesh being compressible to a collapsed configuration for delivery to an endovascular treatment site through a catheter and being self-expandable from the collapsed configuration to an expanded configuration, and wherein, from a first location to a second location along the mesh, each cell distally adjacent to another cell, in a longitudinal row of cells, has a larger interior bounded area than has the another cell, the first and second locations being longitudinally separated by a distance that is more than half of the mesh length;

wherein the mesh is generally cylindrical in the absence of external forces;

wherein each of at least three consecutive cells in the longitudinal row includes first and second struts (i) bounding a proximal portion of the cell and (ii) diverging in a distal direction; and

wherein, in the longitudinal row, each cell distally adjacent to another cell has a larger proximal inscribed strut angle between the first and second struts than has the another cell.

9. The medical device of claim 8, wherein the first and second locations are longitudinally separated by a distance that is at least two thirds of the mesh length.

10. The medical device of claim 8, wherein the first and second locations are longitudinally separated by a distance that is at least three quarters of the mesh length.

11. The medical device of claim 8, wherein the first and second locations are longitudinally separated by a distance that is at least 90% of the mesh length.

12. The medical device of claim 8, wherein the first location is at the proximal mesh end.

13. The medical device of claim 8, wherein the first location is distal to a proximal-most cell.

14. The medical device of claim 8, wherein the second location is at the distal mesh end.

15. The medical device of claim 8, wherein the elongate manipulation member has a length between a proximal end and the distal end portion that is sufficient to permit manipulation of the intervention member within the cerebral vasculature of a patient'"'"'s body from a location outside the body.

16. The medical device of claim 8, wherein the mesh is formed by laser cutting one of a tube or a sheet.

17. The medical device of claim 8, wherein the mesh forms a generally tubular structure.

18. The medical device of claim 8, wherein the mesh further comprises a first lateral edge extending between the proximal mesh end and the distal mesh end, and a second lateral edge opposite the first lateral edge, the second lateral edge extending between the proximal mesh end and the distal mesh end;

wherein the first and second lateral edges are overlapped in a coiled configuration about a longitudinal axis of the mesh when the mesh is in the collapsed configuration.

19. The medical device of claim 8, wherein the mesh has an open proximal end and an open distal end.

20. The medical device of claim 8, wherein the first struts of all cells in the longitudinal row of at least three cells have substantially equal lengths, and

wherein each cell distally adjacent to another cell in the longitudinal row has a larger maximum cell width than has the another cell.

21. A medical device configured to perform an endovascular therapy, the device comprising:

an elongate manipulation member comprising a distal end portion; and

an intervention member comprising a proximal end portion and a plurality of cells forming a mesh, the proximal end portion being coupled with the distal end portion of the elongate manipulation member, the mesh having a proximal mesh end, a distal mesh end, and a mesh length from the proximal end to the distal end, the mesh being compressible to a collapsed configuration for delivery to an endovascular treatment site through a catheter and being self-expandable from the collapsed configuration to an expanded configuration,

wherein, in a longitudinal row of at least three cells, each cell includes first and second struts (i) bounding a proximal portion of the cell and (ii) diverging in a distal direction, and wherein, in the longitudinal row, each cell distally adjacent to another cell has a larger proximal inscribed strut angle between the first and second struts, than has the another cell;

wherein the mesh is generally cylindrical in the absence of external forces; and

wherein each cell distally adjacent to another cell in the longitudinal row has a larger maximum cell width than has the another cell.

22. The medical device of claim 21, wherein each of the first and second struts comprises a straight portion and a curved portion, and the inscribed strut angle is measured between the straight portions of the first and second struts.

23. The medical device of claim 21, wherein the inscribed strut angle is measured between straight reference lines that join strut intersection points at each end of the first and second struts.

24. The medical device of claim 21, wherein the longitudinal row extends from a first location to a second location along the mesh, the first and second locations being longitudinally separated by a distance that is more than half of the mesh length.

25. The medical device of claim 21, wherein, for each cell, the first strut has a length equal to that of the second strut.

26. The medical device of claim 24, wherein the first struts of all cells between the first and second locations have substantially equal lengths.

27. The medical device of claim 24, wherein the first and second locations are longitudinally separated by a distance that is at least two thirds of the mesh length.

28. The medical device of claim 24, wherein the first and second locations are longitudinally separated by a distance that is at least three quarters of the mesh length.

29. The medical device of claim 24, wherein the first and second locations are longitudinally separated by a distance that is at least 90% of the mesh length.

30. The medical device of claim 21, wherein each cell comprises first and second struts (i) bounding a proximal portion of the cell and (ii) diverging in a distal direction, and third and fourth struts (i) bounding a distal portion of the cell and (ii) converging in a distal direction, the maximum cell width is measured from an intersection of the first strut and the third strut to an intersection of the second strut with the fourth strut.

31. The medical device of claim 21, wherein the first struts of all cells in the longitudinal row of at least three cells have substantially equal lengths, and

wherein, in the longitudinal row, each cell distally adjacent to another cell has a larger interior bounded area than has the another cell.